Pathological study of progressive supranuclear palsy the cases with mutations in Bassoon
- PMID: 39478416
- DOI: 10.1111/neup.13009
Pathological study of progressive supranuclear palsy the cases with mutations in Bassoon
Abstract
Clinical diagnosis of progressive supranuclear palsy (PSP) is difficult due to various phenotypes. Neuropathologically, PSP is defined by neuronal loss in the basal ganglia and brainstem with widespread occurrence of neurofibrillary tangles (NFTs) and accumulation of phosphorylated tau protein in neurons and glial cells in the brain. We previously identified the point mutation p.Pro3866Ala in the Bassoon (BSN) gene in a Japanese family with PSP-like syndrome. We newly detected BSN mutations in two autopsied PSP cases carrying p.Thr2542Met and p.Glu2759Gly, respectively. The case with p.Thr2542Met mutation showed neurological symptoms including behavioral abnormalities, cognitive dysfunction, and parkinsonism. Brain magnetic resonance imaging (MRI) showed atrophy of the midbrain tegmentum and hippocampus. Pathologically, moderate to severe loss of neurons with gliosis was also found in the substantia nigra, and there was an almost complete loss of neurons with gliosis in the transitional zone of the cornu ammonis (CA) 1 region to the subiculum. NFTs were observed in the globus pallidus, subthalamic nucleus, substantia nigra, and CA1. 4R tau-dominant tauopathy was detected. The case with p.Glu2759Gly mutation showed neurological symptoms, including right-dominant motor impairment, right limping gait, postural instability, and cognitive dysfunction. Brain MRI showed mild atrophy of the midbrain tegmentum and left-dominant parietal lobe atrophy. Pathologically, NFTs were detected in the globus pallidus, subthalamic nucleus, substantia nigra, thalamus, putamen, and brainstem tegmentum. Most neurons were immunopositive for four-repeat tau, whereas only a few of them harbored three-repeat tau-positive NFTs in the hippocampus. We showed the results of a pathological study of PSP cases with BSN mutations; these were two new cases. The clinical phenotypes were similar to the first case in the point of neurological symptoms. Accumulation of four-repeat tau was dominant. Further autopsies of BSN mutation cases and further elucidation of the molecular biological mechanism are desirable.
Keywords: Bassoon; pathology; progressive supranuclear palsy (PSP); progressive supranuclear palsy‐like syndrome (PSP‐like syndrome).
© 2024 Japanese Society of Neuropathology.
Similar articles
-
Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy.Parkinsonism Relat Disord. 2024 Oct;127:106076. doi: 10.1016/j.parkreldis.2024.106076. Epub 2024 Mar 9. Parkinsonism Relat Disord. 2024. PMID: 38494398
-
Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.Acta Neuropathol Commun. 2023 Jun 1;11(1):88. doi: 10.1186/s40478-023-01584-z. Acta Neuropathol Commun. 2023. PMID: 37264457 Free PMC article.
-
Progressive supranuclear palsy: Neuropathology of patients with a short disease duration due to unexpected death.Neuropathology. 2021 Jun;41(3):174-182. doi: 10.1111/neup.12707. Epub 2020 Nov 17. Neuropathology. 2021. PMID: 33205528
-
Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration.Neuropathology. 2020 Feb;40(1):57-67. doi: 10.1111/neup.12590. Epub 2019 Sep 12. Neuropathology. 2020. PMID: 31515852 Review.
-
Progressive supranuclear palsy: pathology and genetics.Brain Pathol. 2007 Jan;17(1):74-82. doi: 10.1111/j.1750-3639.2007.00054.x. Brain Pathol. 2007. PMID: 17493041 Free PMC article. Review.
Cited by
-
The Genetic Background of the Immunological and Inflammatory Aspects of Progressive Supranuclear Palsy.Int J Mol Sci. 2025 Apr 22;26(9):3927. doi: 10.3390/ijms26093927. Int J Mol Sci. 2025. PMID: 40362170 Free PMC article. Review.
References
REFERENCES
-
- Williams DR, Lees AJ. Progressive supranuclear palsy: Clinicopathological concepts and diagnostic challenges. Lancet Neurol 2009; 8: 270–279.
-
- Yoshida M, Akagi A, Miyahara H et al. Macroscopic diagnostic clue for parkinsonism. Neuropathology 2022; 42: 394–419.
-
- Roemer SF, Grinberg LT, Crary JF et al. Rainwater charitable foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy. Acta Neuropathol 2022; 144: 603–614.
-
- Koizumi R, Akagi A, Riku Y et al. Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy. Parkinsonism Relat Disord 2024; 106076: 106076.
-
- Koga S, Josephs KA, Aiba I, Yoshida M, Dickson DW. Neuropathology and emerging biomarkers in corticobasal syndrome. J Neurol Neurosurg Psychiatry 2022; 93: 919–929.
Publication types
MeSH terms
Substances
Grants and funding
- JP23K27511/Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (KAKENHI)
- JP22K15722/Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (KAKENHI)
- JPMH23FC1008/Ministry of Health Labour and Welfare, Health Labour Sciences Research Grant
- JP22wm0425019/AMED
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous